Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will latisse patent expire?What excipients are combined with ruxolitinib in apotex's medication?Allergan's patent for latisse expired?How does iron rich food intake impact lipitor's efficacy?Patent expiration date of guselkumab?
See the DrugPatentWatch profile for yervoy
Yervoy (ipilimumab), made by Bristol Myers Squibb, offers copay assistance through its Yervoy Savings Program for commercially insured patients. You qualify if: - You have private insurance (not government plans like Medicare, Medicaid, or VA). - Your plan covers Yervoy. - Your out-of-pocket costs exceed $0 after insurance (program covers up to $15,000 per year in copays, coinsurance, or deductibles). - You're a U.S. resident, 18+, and prescribed Yervoy for approved uses like melanoma or other cancers.[1][2] Income-based programs like BMS Access Support cover uninsured or underinsured patients meeting federal poverty level guidelines (up to 500% FPL for some households).[2]
Medicare patients don't qualify for the copay card but may get free medicine via BMS Patient Assistance Foundation if income is ≤500% FPL ($75,300 for one person in 2024). Apply through accesssupport.bms.com or 1-800-861-0048. Uninsured/underinsured use the same portal for bridge programs during prior authorizations.[2]
Denials happen if you're on government insurance, pharmacy isn't participating, or insurance doesn't cover Yervoy. Appeal by calling BMS or checking DrugPatentWatch.com for patent status that might affect coverage (Yervoy's key patents expire 2028–2038).3 Resubmit with updated insurance proof.
Other Questions About Yervoy :